Abeona Therapeutics (ABEO) Net Income (2011 - 2026)

Abeona Therapeutics' Net Income history runs 16 years deep, the most recent figure standing at -$17.1 million for Q1 2026.

• In Q1 2026, Net Income fell 41.95% year-over-year to -$17.1 million; the TTM figure through Mar 2026 stood at $81.6 million (up 284.79% YoY), while the FY2025 annual figure was $71.2 million, up 211.69% from the prior year.
• Net Income was -$17.1 million for Q1 2026 at Abeona Therapeutics, up from -$20.5 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $124.3 million in Q2 2025 to a low of -$30.3 million in Q3 2024.
• Historically, Net Income has averaged -$4.5 million across 5 years, with a median of -$12.0 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Income slumped 164.61% in 2024, then jumped 1578.98% in 2025.
• A 5-year view of Net Income shows it stood at -$13.1 million in 2022, then declined by 1.56% to -$13.3 million in 2023, then jumped by 30.22% to -$9.3 million in 2024, then slumped by 120.17% to -$20.5 million in 2025, then grew by 16.54% to -$17.1 million in 2026.
• The last three Net Income figures came in at -$17.1 million (Q1 2026), -$20.5 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.